Be part of the knowledge.™

Oncology and Hematology

3283

LikeLikedUnlike

Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
- Ryan Quigley
  Peer
- Gregory Vidal, MD, PhD
  Peer
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
The Past, Present, and Future of Metastatic Breast Cancer Care
- Ryan Quigley
  Peer
- Gregory Vidal, MD, PhD
  Peer
Advancing Care for Men with Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Advancing Care for Men with Breast Cancer
- Jose Pablo Leone, MD
  Peer
Personalized Risk Communication and Its Effect on CRC Screening Choice
Clinician's Roundtable
Personalized Risk Communication and Its Effect on CRC Screening Choice
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Clinician's Roundtable
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Clinician's Roundtable
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
advertisement

Q-Challenge™
Advancing Prostate Cancer Care: Integrating Guideline Updates and Patient Prefe…
4 questions
Q-Challenge™
BTK-Based Approach for Managing CLL/SLL
3 questions
Q-Challenge™
Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
4 questions
Q-Challenge™
HER2-Targeted ADCs in Advanced NSCLC
2 questions
Q-Challenge™
Unresectable Hepatocellular Carcinoma: Selecting the Optimal First-Line ICI Com…
10 questions
Q-Challenge™
A Personalized Approach to Perioperative Immunotherapy in Early-Stage Resectabl…
4 questions
advertisement

On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jun Gong, MD
  Peer
Evaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Medical Industry Feature
Evaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Project Oncology®
Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Bridging the Gap in AYA Cure Rates
Medical Industry Feature
Bridging the Gap in AYA Cure Rates
- Ibrahim Aldoss, MD
  Peer
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jaffer Ajani, MD
  Peer
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry Feature
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Komal Jhaveri, MD, FACP
  Peer
- Vanessa Soto-Romano
  Peer

Medical News
Next-Generation PSMA PET Agent Doubles Detection Rates in Early Prostate Cancer…
04/01/2026
Medical News
Dual-Excitation PARS Microscopy Enables High-Fidelity Virtual Multi-Stain Histo…
04/01/2026
Medical News
Aging Reshapes the Human Breast at Cellular and Structural Levels, Offering New…
04/01/2026
Medical News
HER2 Amplification Extends Across Tumor Types, Highlighting New Opportunities f…
04/01/2026
Medical News
CD3 T-Cell Engagers in Solid Tumours: Engineering, Resistance, and Translationa…
03/30/2026
Medical News
Epigenetic Memory of Colitis Linked to Accelerated Tumor Growth
03/27/2026

Program Chapters

Segment Chapters

Playlist:

Recommended